Board Meetings for BALAXI
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 19 Jun 2019 | Other business matters | To consider other business matters and the investment proposals for company��s business expansion. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 03 May 2019 | Financial Results | To consider and approve the financial results for the period ended March 31, 2019 | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 01 Feb 2019 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 09 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 06 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 05 May 2018 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2018 and other business matters | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 12 Feb 2018 | Results/Others | inter alia to consider and approve the following matter; I) Unaudited Financial Results of the company for the Quarter and Nine Months ended on December 31, 2017. ii) To consider and approve the raising of funds through Preferential issue of Securities in terms of the Chapter VII of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, Section 42 and 62(1) of the Companies Act, 2013 read with relevant rules made thereunder and other applicable laws, if any to the persons belonging to Promoter(s)/ Non-Promoter(s) category. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 10 Nov 2017 | Results | inter alia to consider and approve the Un-Audited Financial Results of the Company for the Quarter and Half Year ended on September 30, 2017. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 30 Aug 2017 | Meeting Updates | inter alia to consider the following agenda items along with other items; 1. To discuss and consider the proposal for issue of Equity Shares, by way of Preferential Issue, subject to approval of shareholders of the Company under section 62(1)(c) of the Companies Act, 2013 and other applicable laws. 2. To decide the date, time and venue of Annual General Meeting; 3. To decide the Book Closure dates; 4. To appoint Statutory Auditor for the Company. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 09 Aug 2017 | Results | Inter alia to consider and approve the Un-audited Financial Results of the Company for the Quarter and Three Months ended on June 30, 2017. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 06 Jul 2017 | Others | To Transact/Consider, inter alia the following business. 1. To take note that, Balaxi Overseas Private Limited have become the Promoters of the company. 2. To Change the name of the company to Balaxi Ventures Limited . 3. To consider the proposal for shifting of Registered Office of the company. 4. To amend/alter the Memorandum & Articles of Association. 5. To consider the proposal for increasing the Authorized Capital of the Company. 6. To seek approval of the shareholders for all or any of the above matters and also other matters as may be deemed appropriate. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 25 Apr 2017 | Results | Inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on March 31, 2017. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 28 Jan 2017 | Results | Inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and Nine Months ended on December 31, 2016. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 10 Nov 2016 | Results | inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and Half Year ended on September 30, 2016. | |
| BALAXI | BALAXI PHARMACEUTICALS LIMITED | 30 Jul 2016 | Results | inter alia to consider and approve the Unaudited Financial Results of the company for the Quarter and three months ended on June 30, 2016. |